Will Jackson

Texas A&M Health Science Center — United States

Medicine · Health Sciences

34h-index4.6kcitations417works1.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(128), Prostate Cancer Diagnosis and Treatment(127), Advanced Radiotherapy Techniques(69), Hepatocellular Carcinoma Treatment and Prognosis(19), Statistical Methods in Clinical Trials(16)

Publications417 total

Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer
Prostate Cancer and Prostatic Diseases·2025· 1 citedOpen Access
Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer.
PubMed·2025
Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer
JAMA Oncology·2025· 2 citedOpen Access
Postprostatectomy prostate cancer treated with radiation therapy: adverse features and androgen deprivation therapy use in a statewide consortium
JNCI Cancer Spectrum·2025Open Access
Parotid-Sparing Versus Conventional Whole Brain Radiation Therapy: A Multi-Institutional Randomized Clinical Trial
International Journal of Radiation Oncology*Biology*Physics·2025
Androgen Deprivation Therapy Practice Patterns in High-Risk Prostate Cancer Treated With Definitive Radiotherapy: Prospective Results From a Statewide Quality Consortium
JCO Oncology Practice·2025
The dynamic nature of frailty in metastatic spine disease patients
Journal of Neuro-Oncology·2025Open Access
117. VALIDATION OF THE AGITATION IN ALZHEIMER’S SCREENER FOR CAREGIVERS (AASC®), A NOVEL CLINICAL TOOL TO SCREEN FOR AGITATION IN ALZHEIMER’S DEMENTIA
American Journal of Geriatric Psychiatry·2025
Vascular smooth muscle cell atherosclerosis trajectories characterized at single cell resolution identify causal transcriptomic and epigenomic mechanisms of disease risk
2025· 2 citedOpen Access
Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men
JCO Precision Oncology·2025
1650 Preliminary results of a phase II randomized control trial of neurovascular-sparing SAbR in localized prostate cancer [PCa] (POTEN-C, NCT03525262)
Radiotherapy and Oncology·2025· 1 cited
Increasing Naloxone Prescriptions for Outpatient Cancer Patients Co-Prescribed Opioids and Benzodiazepines
Journal of Pain and Symptom Management·2025
Carcinoma of prostate sequencing of tumor and clinical endpoints (CAPSTONE): Clinical implications of recurrent genomic alterations in lethal prostate cancer.
Journal of Clinical Oncology·2025
Androgen suppression with abiraterone acetate, leuprolide, PARP inhibition, and stereotactic body radiotherapy (ASCLEPIuS) in high-risk and node positive prostate cancer (PCa): Phase I multicenter results.
Journal of Clinical Oncology·2025· 1 cited
Impact of PSMA PET staging on initial treatment in newly diagnosed prostate cancer: An emulated randomized controlled trial.
Journal of Clinical Oncology·2025
Contemporary post-prostatectomy radiation therapy for prostate cancer within a statewide quality consortium.
Journal of Clinical Oncology·2025
Separation Surgery Followed by Conformal Postoperative Spine Stereotactic Body Radiation Therapy Does Not Increase Risk of Adjacent Spine Level Progression in the Management of Spine Metastases
American Journal of Clinical Oncology·2025· 4 cited
Shift work schedules alter immune cell regulation and accelerate cognitive impairment during aging
Journal of Neuroinflammation·2025· 5 citedOpen Access
Rates of PSMA PET Staging and Positivity in Newly Diagnosed Prostate Cancer in a National Health Care System
Journal of Nuclear Medicine·2025· 8 citedOpen Access
Shift Work Schedules Alter Immune Cell Regulation and Accelerate Cognitive Impairment during Aging
2024Open Access
page 1 of 21Next →

Frequent Co-authors

Felix Y. Feng(27), Robert T. Dess(24), Daniel E. Spratt(24), Matthew J. Schipper(21), Todd M. Morgan(19), Rohit Mehra(18), Howard M. Sandler(11), Amar U. Kishan(10), Paul L. Nguyen(9), Holly Hartman(8), Zachary S. Zumsteg(8), Samuel D. Kaffenberger(8), Daniel A. Hamstra(8), Brandon A. Mahal(7), Simpa S. Salami(7), Edward M. Schaeffer(7), Theodore S. Lawrence(7), Thomas M. Pisansky(6), Jason W.D. Hearn(6), Yilun Sun(6)